Back to BlackRock, Inc. BlackRock, Inc.

MRNSMRNS
3 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in MARINUS PHARMACEUTICALS INC

As of its Q4 2024 13F, BlackRock held 883,675 shares of MRNS (Marinus Pharmaceuticals), worth $472,854. BlackRock's 13F filings listed MRNS from Q3 2024 to Q4 2024, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3.3M

Total Shares Change

-1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Decreased
883,675
-52.5%
$472,8540.0%—
0
2024-Q3
First report
1.9M
-
$3.3M0.0%—
0

Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used